Clinical Signficance of p53, Proliferating Cell Nuclear Antigen and bcl-2 Expression in Bladder Transitional Cell Carcinoma

By Zhu Zhaohui   Cheng Ping   Zeng Fuqing   Lu Gongcheng   Xing Shian  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 20-23

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma

By Deveci M. Salih   Deveci Güzin  

Gastric Cancer, Vol. 10, Iss. 2, 2007-06 ,pp. : 112-116

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Topoisomerase IIα, Ki-67, Proliferating Cell Nuclear Antigen, p53, and Argyrophilic Nucleolar Organizer Regions in Vulvar Squamous Lesions

By Brustmann H.   Naudé S.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 192-199

Academic Press

Access to resources Recommend Favorite

Proliferating Cell Nuclear Antigen in Endometrial Carcinoma: Pretreatment Identification of High-Risk Patients

By Garzetti G.G.   Ciavattini A.   Goteri G.   de Nictolis M.   Romanini C.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 16-21

Academic Press

Access to resources Recommend Favorite

Prognostic Significance of Ki-67 Nuclear Proliferative Antigen, bcl-2 Protein, and p53 Expression in Follicular and Diffuse Large B-Cell Lymphoma

By Llanos M.   Alvarez-Argüelles H.   Alemán R.   Oramas J.   Díaz-Flores L.   Batista N.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 15-22

Humana Press, Inc

Access to resources Recommend Favorite